Post-Acne PIH in Skin of Color
The most common real-world acne complaint in Fitzpatrick IV–VI is not the acne but the dark marks it leaves — how to resolve post-acne post-inflammatory hyperpigmentation with gentle acids, mandelic and azelaic chemistry, tyrosinase inhibition and disciplined photoprotection, without provoking more pigment.
In Fitzpatrick IV–VI, the most common real-world acne complaint is not the acne — it is the brown marks it leaves behind. Post-acne post-inflammatory hyperpigmentation (PIH) is what brings these patients in, distresses them most, and lasts long after the pimple has gone. The treatment principle follows directly from the pathophysiology: PIH is pigment laid down in response to inflammation, so the work is to switch off the inflammation (control the acne), fade the existing pigment with gentle, low-irritation acids and tyrosinase inhibition, and protect relentlessly from UV — all while remembering that the same inflammation that fades is the inflammation an aggressive peel re-creates. Gentleness is not timidity here; it is the mechanism.
Why PIH dominates the picture in IV–VI
Melanocytes in darker skin are more labile — they respond to inflammatory and UV signals by producing more pigment, more readily, and that pigment can sit in the epidermis or drop into the dermis where it is slower to clear. So in skin of color, an acne lesion that would resolve cleanly in lighter skin instead leaves a dark macule that outlives the acne by months.
This is the defining tension of the lesson: the instinct to treat dark marks aggressively is exactly wrong, because aggression is inflammation, and inflammation is the cause of PIH. The patient does not need a stronger peel; they need the acne controlled and a patient, low-irritation fading programme.
The treatment architecture
Four moves, in priority order.
| Step | Move | Why it works |
|---|---|---|
| 1 | Switch off the inflammation | Control the active acne — every lesion prevented is a dark mark prevented. This is the primary treatment. |
| 2 | Inhibit tyrosinase | Topical tyrosinase inhibitors (azelaic acid, kojic acid, others) reduce new pigment production at the source. |
| 3 | Fade with gentle acids | Mandelic and azelaic chemistry accelerate turnover of pigmented corneocytes with low irritation — no inflammatory rebound. |
| 4 | Photoprotect relentlessly | UV (and visible light) drives melanogenesis; unprotected sun reverses every gain. Photoprotection is treatment, not a footnote. |
Azelaic acid earns a special place because it does two jobs at once: it is an effective anti-inflammatory acne agent and a tyrosinase inhibitor, so it treats the cause (acne inflammation) and the consequence (pigment) simultaneously. Mandelic acid is the gentle resurfacing workhorse — its large molecule penetrates slowly and evenly with low irritation, which is precisely what labile, PIH-prone skin needs. Together, mandelic and azelaic chemistry treat the acne and fade the pigment without the inflammatory rebound that a fast, small-molecule peel would cause.
A caution on shortcuts patients ask for: high-strength hydroquinone misuse over long periods can produce exogenous ochronosis (paradoxical darkening), and aggressive peels or lasers in IV–VI can convert PIH into a worse, longer-lasting pigment problem. The discipline is to keep every step low-inflammation and to treat photoprotection as part of the prescription, not advice tacked on at the end.
Running the fading programme
- Control the acne first
Get the active acne under medical control. There is no point fading marks while new lesions keep seeding new ones — the acne is the tap, the PIH is the puddle.
- Start gentle topicals
A tyrosinase inhibitor (azelaic acid is ideal — dual acne-and-pigment action) plus a sensible turnover agent, introduced at a tolerable cadence to avoid irritant dermatitis that would itself cause PIH.
- Add gentle in-clinic peels
Mandelic or azelaic-led superficial peels as a low-irritation series — to accelerate fading, not to force it. Build across sessions; never chase a dramatic single-session result in IV–VI.
- Photoprotect as treatment
Broad-spectrum protection, reapplied, with attention to visible light. Counsel that without this, the programme cannot work — UV undoes the fading in real time.
Key takeaway
In skin of color the dark marks usually matter more to the patient than the acne itself, and post-acne PIH is pigment laid down in response to inflammation. So the plan is: switch off the inflammation by controlling the active acne, inhibit tyrosinase and fade existing pigment with gentle, low-irritation acids — mandelic and azelaic chemistry are the workhorses, with azelaic doing double duty as both acne agent and tyrosinase inhibitor — and protect relentlessly from UV, because photoprotection is treatment rather than advice. Above all, resist the urge to be aggressive: the inflammation an over-strong peel creates is the very thing that makes PIH, so gentleness is the mechanism, not a compromise.
Frequently asked questions
Why is post-acne PIH the main complaint in darker skin?
Because melanocytes in Fitzpatrick IV–VI are more labile — they respond to inflammation and UV by producing more pigment, more readily, and that pigment can settle in the epidermis or drop into the dermis where it clears slowly. So an acne lesion that would resolve cleanly in lighter skin instead leaves a dark mark that outlasts the acne by months. Patients are usually far more distressed by these marks than by the active pimples, which is why PIH dominates the real-world acne consultation in skin of color.
How do I fade post-acne dark marks without causing more pigment?
Keep every step low-inflammation, because inflammation is what causes PIH in the first place. Control the active acne, use tyrosinase inhibitors such as azelaic acid, fade with gentle mandelic or azelaic-led superficial peels run as a patient series rather than an aggressive single session, and photoprotect relentlessly. Avoid the instinct to use stronger peels or lasers to clear marks faster — the added inflammation re-creates the PIH. In skin of color, gentleness is the mechanism, not timidity.
Why is azelaic acid especially useful for post-acne PIH?
Because it does two jobs at once. Azelaic acid is an effective anti-inflammatory and antimicrobial acne agent, so it helps switch off the inflammation that is the upstream cause of PIH, and it is also a tyrosinase inhibitor, so it reduces new pigment production at the source. Treating the cause and the consequence in a single agent makes it a natural fit for post-acne pigmentation in skin of color, and it is generally well tolerated in darker, reactive skin.
Is post-acne PIH a scar, and does it need laser treatment?
No — flat post-acne dark marks are pigment, not scars, and they fade over months with medical treatment and photoprotection. A true atrophic scar is a contour defect that casts a shadow under side lighting and needs structural remodelling; a flat dark mark does not. Treating PIH with scar devices or aggressive lasers risks adding inflammation and making the pigment worse. Reserve devices for genuine contour scars, and treat PIH gently with topicals, low-irritation acids and sun protection.
References
Related protocols
Go deeper: Post-Inflammatory Hyperpigmentation in Skin of Color: A Clinician's Treatment Algorithm →